What is the appropriate diagnosis and management for a patient with months-long facial flushing and numbness (paresthesia) of the forehead triggered by hot showers and lasting several hours?

Rosacea with Neurological Features

This presentation is most consistent with rosacea, specifically the erythematotelangiectatic phenotype with associated neurological symptoms, and requires phenotype-based topical therapy combined with trigger avoidance and evaluation for ocular involvement.

Diagnostic Reasoning

The clinical picture of facial flushing triggered by hot showers, lasting hours, and occurring over months with facial numbness strongly suggests rosacea. According to the 2017 Global Rosacea Consensus (ROSCO) panel, persistent centrofacial erythema associated with periodic intensification is independently diagnostic for rosacea 1. The hot shower trigger is a classic exacerbating factor, as heat exposure is a well-documented rosacea trigger 2.

The numbness/paresthesia of the forehead warrants careful consideration. While not a typical primary feature of rosacea, the 2024 ophthalmology guidelines note that rosacea patients often present with subtle neurological symptoms that can be overlooked 2. The combination of flushing with paresthesia could represent:

• Rosacea with associated neuropathic features (most likely given the chronic, trigger-based pattern)
• Harlequin syndrome (less likely - typically unilateral and associated with sweating asymmetry) 3
• Red flag conditions requiring exclusion (see below)

Critical Red Flags to Exclude

Before confirming rosacea, you must actively exclude:

1. Progressive facial nerve palsy or persistent trigeminal neuralgia - These can indicate perineural spread of cutaneous squamous cell carcinoma, particularly in immunocompromised patients or those with facial sun damage history. The median time to diagnosis is 12-19 months due to misdiagnosis 4.

2. Carcinoid syndrome, pheochromocytoma, or mastocytosis - These cause episodic flushing but typically include systemic symptoms (diarrhea, hypertension, urticaria) 5, 6.

3. Stroke or brainstem lesion - Sudden onset unilateral symptoms with Horner's syndrome features would suggest vascular etiology 3.

Specific Examination Findings to Document

• Facial erythema pattern: Centrofacial distribution, presence of telangiectasia, papules/pustules
• Paresthesia characteristics: Unilateral vs bilateral, specific trigeminal nerve distribution (V1/forehead suggests ophthalmic division)
• Ocular examination: Check for blepharitis, meibomian gland dysfunction, conjunctival injection - ocular rosacea occurs in 37-52% of cases and can precede cutaneous findings 2, 7, 8
• Skin texture: Look for sebaceous gland prominence, phymatous changes
• Symmetry: Asymmetric findings raise concern for structural lesions

Management Algorithm

Step 1: Initial Topical Therapy

Start with FDA-approved topical agents for inflammatory rosacea phenotype:

• Encapsulated benzoyl peroxide 5% (E-BPO) - Shows efficacy by week 2 with excellent tolerability and sustained results up to 52 weeks 9
• Alternative options: Metronidazole gel, azelaic acid gel/foam, or ivermectin cream 9

Step 2: Trigger Avoidance (Critical for Symptom Control)

• Eliminate hot water exposure: Use lukewarm water for face washing and showering
• Avoid other common triggers: alcohol, spicy foods, extreme temperatures, emotional stress
• Use gentle, non-irritating skincare products 9, 1

Step 3: Address Neurological Symptoms

The facial numbness requires specific attention:

• If paresthesia persists beyond 2-4 months despite rosacea treatment, obtain gadolinium-enhanced MR neurography to exclude perineural spread or structural lesions 4
• Document progression: Worsening or spreading paresthesia is a red flag
• Consider neuropathic pain management if symptoms are bothersome (though this is unusual in uncomplicated rosacea)

Step 4: Evaluate for Ocular Involvement

Mandatory ophthalmology referral if:

• Eye irritation, burning, or foreign body sensation
• Recurrent chalazia or blepharitis
• Visual changes
• Children (ocular symptoms often precede cutaneous findings) 2, 7

Step 5: Consider Systemic Therapy

If topical therapy fails after 8-12 weeks:

• Low-dose doxycycline (40mg modified-release) for anti-inflammatory effects 9
• Avoid standard-dose antibiotics unless bacterial superinfection present

Common Pitfalls

1. Dismissing the numbness as anxiety: While rosacea can cause psychological distress, persistent paresthesia in a specific nerve distribution requires investigation 4.

2. Failing to recognize ocular rosacea: This occurs in up to 52% of patients and can cause sight-threatening complications if untreated 2.

3. Allowing patients to continue ice water immersion: Many patients self-treat flushing with cold water, which can cause tissue damage and worsen symptoms long-term 10.

4. Missing rosacea in darker skin tones: Erythema and telangiectasia are difficult to visualize; rely more on patient-reported flushing history and palpable texture changes 2, 1.

When to Escalate Care

Obtain urgent imaging (MRI brain with gadolinium) if:

• Progressive or worsening paresthesia
• Development of facial weakness
• Unilateral symptoms only
• History of skin cancer or immunosuppression
• Age >50 with new-onset symptoms (consider giant cell arteritis) 2

The phenotype-based approach endorsed by the 2020 ROSCO panel emphasizes treating the specific features most troubling to the patient rather than following rigid subtype algorithms 9, 1. In this case, addressing both the flushing (with topical therapy and trigger avoidance) and monitoring the neurological symptoms (with appropriate imaging if persistent) provides the most patient-centered care.